BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Molaei F, Forghanifard MM, Fahim Y, Abbaszadegan MR. Molecular Signaling in Tumorigenesis of Gastric Cancer. Iran Biomed J. 2018;22:217-230. [PMID: 29706061 DOI: 10.22034/ibj.22.4.217] [Cited by in F6Publishing: 16] [Reference Citation Analysis]
Number Citing Articles
1 Chen QH, Wu BK, Pan D, Sang LX, Chang B. Beta-carotene and its protective effect on gastric cancer. World J Clin Cases 2021; 9(23): 6591-6607 [PMID: 34447808 DOI: 10.12998/wjcc.v9.i23.6591] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
2 Yang L, Zhao KL, Qin L, Ji DX, Zhang B, Zheng PF, Qin YM. Notch signaling pathway regulates CD4+CD25+CD127dim/- regulatory T cells and T helper 17 cells function in gastric cancer patients. Biosci Rep 2019;39:BSR20182044. [PMID: 30988066 DOI: 10.1042/BSR20182044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
3 Weidle UH, Birzele F, Nopora A. microRNAs Promoting Growth of Gastric Cancer Xenografts and Correlation to Clinical Prognosis. Cancer Genomics Proteomics 2021;18:1-15. [PMID: 33419892 DOI: 10.21873/cgp.20237] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang F, Maswikiti EP, Wei Y, Wu W, Li Y. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer. Dis Markers 2021;2021:5567392. [PMID: 34422135 DOI: 10.1155/2021/5567392] [Reference Citation Analysis]
5 Zhang Y, Yan J, Li C, Wang X, Dong Y, Shen X, Zhang X. LncRNA H19 induced by helicobacter pylori infection promotes gastric cancer cell growth via enhancing NF-κB-induced inflammation. J Inflamm (Lond) 2019;16:23. [PMID: 31787851 DOI: 10.1186/s12950-019-0226-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
6 Zhao DY, Sun XZ, Yao SK. Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer. World J Gastrointest Oncol 2021; 13(1): 37-57 [PMID: 33510848 DOI: 10.4251/wjgo.v13.i1.37] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Luo T, Li Y, Nie R, Liang C, Liu Z, Xue Z, Chen G, Jiang K, Liu ZX, Lin H, Li C, Chen Y. Development and validation of metabolism-related gene signature in prognostic prediction of gastric cancer. Comput Struct Biotechnol J 2020;18:3217-29. [PMID: 33209209 DOI: 10.1016/j.csbj.2020.09.037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Nakonieczna S, Grabarska A, Kukula-Koch W. The Potential Anticancer Activity of Phytoconstituents against Gastric Cancer-A Review on In Vitro, In Vivo, and Clinical Studies. Int J Mol Sci 2020;21:E8307. [PMID: 33167519 DOI: 10.3390/ijms21218307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Xie Y, Liu Z, Zhu H. Knockdown of hsa_circ_0091994 constrains gastric cancer progression by suppressing the miR-324-5p/HMGA1 axis. Aging (Albany NY) 2021;13:20598-608. [PMID: 34483139 DOI: 10.18632/aging.203450] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ma F, Li X, Ren J, Guo R, Li Y, Liu J, Sun Y, Liu Z, Jia J, Li W. Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer. Cell Death Dis 2019;10:623. [PMID: 31423012 DOI: 10.1038/s41419-019-1846-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
11 Mao D, Xu R, Chen H, Chen X, Li D, Song S, He Y, Wei Z, Zhang C. Cross-Talk of Focal Adhesion-Related Gene Defines Prognosis and the Immune Microenvironment in Gastric Cancer. Front Cell Dev Biol 2021;9:716461. [PMID: 34660578 DOI: 10.3389/fcell.2021.716461] [Reference Citation Analysis]
12 Cao J, Zhang X, Xu P, Wang H, Wang S, Zhang L, Li Z, Xie L, Sun G, Xia Y, Lv J, Yang J, Xu Z. Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway. J Exp Clin Cancer Res 2021;40:6. [PMID: 33397440 DOI: 10.1186/s13046-020-01791-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
13 Li X, Chen W, Yang C, Huang Y, Jia J, Xu R, Guan S, Ma R, Yang H, Xie L. IGHG1 upregulation promoted gastric cancer malignancy via AKT/GSK-3β/β-Catenin pathway. Cancer Cell Int 2021;21:397. [PMID: 34315496 DOI: 10.1186/s12935-021-02098-1] [Reference Citation Analysis]
14 Zhang Y, Guo D. Epigenetic Variation Analysis Leads to Biomarker Discovery in Gastric Adenocarcinoma. Front Genet 2020;11:551787. [PMID: 33363566 DOI: 10.3389/fgene.2020.551787] [Reference Citation Analysis]
15 Zhang Z, Zhu X. Clinical Significance of Lysophosphatidic Acid Receptor-2 (LPA2) and Krüppel-Like Factor 5 (KLF5) Protein Expression Detected by Tissue Microarray in Gastric Adenocarcinoma.Med Sci Monit. 2019;25:4705-4715. [PMID: 31235682 DOI: 10.12659/MSM.916336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
16 Pajuelo-Lozano N, Alcalá S, Sainz B Jr, Perona R, Sanchez-Perez I. Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines. Theranostics 2020;10:9601-18. [PMID: 32863948 DOI: 10.7150/thno.49270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kang W, Zhang J, Huang T, Zhou Y, Wong CC, Chan RCK, Dong Y, Wu F, Zhang B, Wu WKK, Chan MWY, Cheng ASL, Yu J, Wong N, Lo KW, To KF. NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway. Oncogene 2021;40:1578-94. [PMID: 33452458 DOI: 10.1038/s41388-020-01579-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]